Coston, Mc Isaac & Partners Viatris Inc Transaction History
Coston, Mc Isaac & Partners
- $281 Million
- Q4 2024
A detailed history of Coston, Mc Isaac & Partners transactions in Viatris Inc stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 1,165 shares of VTRS stock, worth $13,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,165
Previous 1,552
24.94%
Holding current value
$13,094
Previous $18,000
22.22%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
986MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.6 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.04 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$717 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$703 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$660 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...